The Therapeutic Goods Administration fined Mundipharma AU$302,400 while also serving it 24 infringement notices. The claims in question dealt with the drug’s effectiveness managing chronic non-cancer pain. The company has since removed the flagged language.
Estimated reading time: 0 minutes, 20 seconds
Most Read
-
-
Nov 01 2023
-
Written by CMO Tech News
-
-
-
Nov 30 2023
-
Written by CMO Tech News
-
-
-
Dec 08 2023
-
Written by CMO Tech News
-
-
-
Nov 30 2023
-
Written by CMO Tech News
-